Novocell's Human Stem Cells, Treat Diabetes in Mice

Filed in archive Developments , Research , Treatment on April 9, 2008

Based in San Diego, California (USA), Novocell Inc. has found a potential in their human embryonic stem cells for diabetes cure.





As reported by Novocell's team of researchers in the journal Nature Biotechnology:

Human stem cells transformed into nearly normal insulin-producing cells when implanted into mice, possibly offering a way to treat diabetes long-term.

The researchers used human embryonic stem cells - the most powerful but the most controversial source of stem cells.

"Our data provide the first compelling evidence that human embryonic stem cells can serve as a renewable source of functional insulin-producing cells for diabetes cell replacement therapies," said Emmanuel Baetge, chief scientific officer of Novocell.

Yes, human embryonic stem cells are indeed the most powerful of stem cells, BUT the most controversial.

So, let's wait and see how this goes.